Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
But what sets us apart from the rest
Personalized longevity programs are built around your diagnostic results, lifestyle, and longterm goals
It's still a cosmetic ingredient, not a drug , which means the regulatory bar for evidence is lower than for pharmaceutical approval
US$ 25.59
US$ 25.85
US$ 26.70
US$ 23.10
